1415794-01-2

Upstream product

• 1415794-00-1 4-(4-bromophenyl)-2-methylmorpholine 
• 25015-63-8 4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane 
• 1415794-69-2 C₁₁H₁₄N₂O₃ 
• 926236-16-0 4-(2-methylmorpholino)aniline 
• 27550-90-9 2-methylmorpholine 
• 350-46-9 4-Fluoronitrobenzene 
• 73183-34-3 bis(pinacol)diborane 

Relevant academic research and scientific papers

6H-IMIDAZO[1,5-a]PYRROLO[2,3-e]PYRAZINE COMPOUNDS

The invention provides a compound of Formula (I) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS

Provided are pyridopyrazine compounds of formula (1), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.

SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS

The present invention relates to pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, L, m, p and W are as defined in the specification.